Johnson & Johnson (NYSE:JNJ) – U.S. guidelines expand potential uses of J&J TB drug

[Reuters] – New federal guidelines expand the range of patients who might benefit from Johnson & Johnson’s Sirturo drug for the treatment of multi-drug-resistant tuberculosis , the first new type of TB drug . . . → Read More: Johnson & Johnson (NYSE:JNJ) – U.S. guidelines expand potential uses of J&J TB drug Similar posts: Stock Update: Wal-Mart Stores Inc. (NYSE:WMT) – Wal-Mart to expand in China with 110 new stores [at MarketWatch] – The retailer is shifting its strategy... Stock Update: Johnson & Johnson (NYSE:JNJ) – J&J’s new hepatitis C drug gets positive FDA review [Reuters] – A new hepatitis C drug made by... Company Update: Johnson & Johnson (NYSE:JNJ) – One Put, One Call Option To Know About for Johnson & Johnson [at Forbes] – Consistently, one of the more popular...